The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Does Mounjaro Work Immediately? What the Clinical Trials Show
Mounjaro (tirzepatide) does not produce immediate weight loss results — both Mounjaro and Wegovy (semaglutide) require several weeks to build up in your system before significant effects appear. The clinical trials show weight loss typically becomes noticeable after 4–8 weeks of treatment, with more substantial results developing over 12–16 weeks. Understanding how quickly these medications actually work, and how they compare to each other, helps set realistic expectations before starting prescription weight loss treatment in the UK.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Quickly Does Mounjaro Work — SURMOUNT Trial Timeline
The SURMOUNT-1 clinical trial, which tested Mounjaro (tirzepatide), provides the most reliable data on how quickly the medication works. Here's the realistic timeline:
- Weeks 1–4: Starting dose (2.5 mg). Most people experience mild appetite reduction but minimal weight change. Nausea is common during this phase.
- Weeks 5–8: First dose increase to 5 mg. Appetite suppression increases; some users report noticing clothes fitting differently. Average weight loss still modest at this stage.
- Weeks 9–16: Further dose escalations (7.5 mg, 10 mg). Noticeable weight loss becomes more consistent. Participants in trials saw measurable changes on the scale.
- Weeks 17+: At maximum dose (15 mg), sustained weight loss continues. Peak results typically appear at 52–72 weeks of treatment.
The dual GIP and GLP-1 mechanism of Mounjaro means it takes time for both pathways to reach therapeutic effect. This is not a structured approach — it's a gradual process requiring patience and commitment to diet and activity changes.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro vs Wegovy — How the Timelines Compare
Wegovy (semaglutide) follows a similar timeline because both are GLP-1 receptor agonists requiring dose titration over weeks. The STEP-1 trial showed comparable patterns: minimal loss in weeks 1–4, noticeable changes by weeks 9–12, and peak results at 52–68 weeks. The key difference is mechanism: Wegovy activates only the GLP-1 pathway, whilst Mounjaro activates both GIP and GLP-1. Clinical data suggests Mounjaro may produce slightly greater average weight loss (around 20.9% at 15 mg vs 14.9% for Wegovy at 2.4 mg in trials), but individual results vary significantly. Neither medication works immediately. Your prescriber will assess which is more suitable for you based on your health profile, and both require a clinical assessment before prescription. Using our GLP-1 weight loss calculator can help you understand potential outcomes at different doses.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Why doesn't Mounjaro work immediately?
Mounjaro works by gradually building up in your system over weeks. The starting dose (2.5 mg) is low intentionally to allow your body to adjust and minimise side effects. Subsequent weekly dose increases allow both the GIP and GLP-1 receptors to reach therapeutic levels. Full appetite-suppressing effects typically develop over 8–12 weeks of consistent dosing.
When should I expect to see weight loss on Mounjaro?
Most people notice the first measurable weight loss around weeks 4–8, though this varies. Significant, noticeable results typically appear by weeks 12–16. Peak results are usually seen at 20–24 weeks (approximately 5–6 months) on a stable dose. Always combine treatment with a reduced-calorie diet and increased physical activity.
Is Mounjaro faster than Wegovy?
Clinical trials suggest Mounjaro may produce slightly greater average weight loss than Wegovy, but both work on similar timelines. The SURMOUNT trial (Mounjaro) showed ~20.9% average loss; the STEP trial (Wegovy) showed ~14.9%. However, individual responses vary greatly, and your prescriber will recommend the medication most suited to your health circumstances.
Can I get Mounjaro through the NHS?
Yes, NICE has approved tirzepatide (Mounjaro) for NHS use within specialist tier 3 weight management services. However, NHS access varies significantly by region and involves referral through your GP. Waiting lists can be lengthy. Private prescription access is available through online clinical assessment with a UK-licensed prescriber.
What lifestyle changes should I make while taking Mounjaro?
Mounjaro works best alongside a reduced-calorie diet (typically 500 kcal daily deficit) and regular physical activity. The medication reduces appetite, but it does not clinically studied weight loss without these changes. Your GP or prescriber will discuss a personalised plan. Track your progress using our free progress tracker to monitor changes over time.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.